Senior M&A Reporter US - Intelligence Origination
Gain Therapeutics
This listing was originally posted on Gain Therapeutics's careers page. Formulate is an equal opportunity job aggregator and is not involved in the hiring process. Where salary information is estimated, it is derived from BLS industry benchmarks and may differ from actual compensation.
Upgrade to Pro to access the AI-generated 'Read before applying' briefing and other premium pharma intelligence.
Upgrade to Pro — $25/moWho are we?
Gain is the Private Markets Super App, a connected global platform transforming how leading investors, advisors, and corporates source, evaluate, and execute deals. By combining investment-grade intelligence, AI-powered workflows, proprietary data and news in one unified platform, Gain enables top deal teams to move faster, reduce risk, and build conviction with confidence.
Gain is trusted across more than $1 trillion of private capital, used by 100% of MBB and Big Four firms, and by 80% of the world’s top 20 M&A advisory houses.
Recognized for fast innovation and impact, Gain has been named both US and EU Data Provider of the Year by PE Wire, awarded Global Financial Market Review’s Best Use of AI in Finance, and ranked in Sifted’s Top 100 Fastest-Growing Companies, the Forbes 1000, and the Deloitte Technology Fast 50. Gain operates globally with offices in New York, London, Amsterdam, Frankfurt, Warsaw, and Bangalore.
Explore related positions you might be interested in
We'll notify you when matching roles are posted.
Interviewed at Gain Therapeutics?
Help others prepare — share your experience anonymously.
BIOTECHNOLOGY
Site-directed Enzyme Enhancement Therapy
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo